Affiliation: University of Western Australia
Chee J, Robinson B, Holt R, Creaney J. Immunotherapy for Lung Malignancies: From Gene Sequencing to Novel Therapies. Chest. 2017;151:891-897 pubmed publisher
Khong A, Cleaver A, Fahmi Alatas M, Wylie B, Connor T, Fisher S, et al
. The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40. BMC Cancer. 2014;14:969 pubmed publisher
..Both adjuvants are available for clinical use/trial, hence this treatment regimen has clear translational potential. ..
Robinson C, Dick I, Wise M, Holloway A, Diyagama D, Robinson B, et al
. Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma. BMC Cancer. 2015;15:983 pubmed publisher
..Of particular note, MexTAg mesothelioma development was not dependent on cdkn2 deletion. ..
Aston W, Hope D, Nowak A, Robinson B, Lake R, Lesterhuis W. A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice. BMC Cancer. 2017;17:684 pubmed publisher
Sneddon S, Patch A, Dick I, Kazakoff S, Pearson J, Waddell N, et al
. Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma. BMC Cancer. 2017;17:396 pubmed publisher
Johnen G, Gawrych K, Raiko I, Casjens S, Pesch B, Weber D, et al
. Calretinin as a blood-based biomarker for mesothelioma. BMC Cancer. 2017;17:386 pubmed publisher
..Molecular markers like calretinin and mesothelin are promising tools to improve and supplement the diagnosis of MM and warrant further validation in a prospective study. ..